Steven M Devine

Steven M Devine

UNVERIFIED PROFILE

Are you Steven M Devine?   Register this Author

Register author
Steven M Devine

Steven M Devine

Publications by authors named "Steven M Devine"

Are you Steven M Devine?   Register this Author

100Publications

2863Reads

39Profile Views

Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 Jun 20. Epub 2019 Jun 20.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.014DOI Listing
June 2019

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Leuk Lymphoma 2019 Feb 15:1-7. Epub 2019 Feb 15.

a Department of Pharmacy, The James Cancer Hospital , The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573996DOI Listing
February 2019

A challenge to discriminating psychosocial eligibility criteria: exploring the ethical justification for excluding patients with psychosocial risk factors from hematopoietic cell transplantation.

Bone Marrow Transplant 2018 11 6;53(11):1474-1477. Epub 2018 Jun 6.

Center for Bioethics and Medical Humanities, and Department of Palliative Care, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0213-6
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0213-6DOI Listing
November 2018

Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide: Does Graft Source Matter?

Authors:
Steven M Devine

J Clin Oncol 2017 09 10;35(26):2984-2986. Epub 2017 Jul 10.

Steven M. Devine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.73.7775
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.73.7775DOI Listing
September 2017

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

J Clin Oncol 2017 Apr 13;35(11):1154-1161. Epub 2017 Feb 13.

Bart L. Scott and H. Joachim Deeg, Fred Hutchinson Cancer Research Center, Seattle, WA; Marcelo C. Pasquini, Brent R. Logan, Mehdi Hamadani, and Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; Juan Wu and Adam M. Mendizabal, Emmes Corporation, Rockville, MD; Steven M. Devine, Ohio State University Comprehensive Cancer Center, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Erica D. Warlick, University of Minnesota, Minneapolis; Jennifer Le-Rademacher, Mayo Clinic, Rochester, MN; Hugo F. Fernandez, Moffitt Cancer Center, Tampa, FL; Edwin P. Alyea, Dana Farber Cancer Institute, Boston, MA; Asad Bashey, Northside Hospital Cancer Institute, Atlanta, GA; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Nancy L. Geller and Eric Leifer, National Heart, Lung, and Blood Institute, Bethesda, MD; and Mitchell E. Horwitz, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.7091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455603PMC
April 2017

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Neurology 2017 Feb 1;88(9):842-852. Epub 2017 Feb 1.

From the Colorado Blood Cancer Institute (R.A.N.), Denver; Baylor College of Medicine (G.J.H.), Houston, TX; Ohio State University (M.K.R., S.M.D.), Columbus; MD Anderson Cancer Research Center (U.P.), Houston, TX; Rho, Inc. (K.C.S.), Chapel Hill, NC; National Institute of Allergy and Infectious Diseases (L.M.G.), National Institutes of Health, Bethesda, MD; Division of Brain Sciences (P.A.M.), Imperial College London, UK; City of Hope National Medical Center (H.O.), Duarte, CA; Immune Tolerance Network (P.H.S.), University of California San Francisco; University of Texas Southwestern (O.S.), Dallas; NeuroRx (D.L.A.), McGill University, Montreal, Canada; Fred Hutchinson Cancer Research Center (G.E.G.), University of Washington (M.H.W., A.W., G.H.K.); and Swedish Hospital Medical Center (J.D.B.), Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331868PMC
February 2017

Practice Patterns and Preferences Among Hematopoietic Cell Transplantation Clinicians.

Biol Blood Marrow Transplant 2016 11 29;22(11):2092-2099. Epub 2016 Jul 29.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067220PMC
http://dx.doi.org/10.1016/j.bbmt.2016.07.014DOI Listing
November 2016

Tocilizumab for steroid refractory acute graft-versus-host disease.

Leuk Lymphoma 2016 3;57(1):81-5. Epub 2015 Jul 3.

b Division of Hematology, Department of Internal Medicine , James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1045896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698359PMC
October 2016

How do stem cells mobilize? Bridging the GAP.

Authors:
Steven M Devine

Blood 2016 09;128(11):1445-6

THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2016-07-72
Publisher Site
http://dx.doi.org/10.1182/blood-2016-07-726414DOI Listing
September 2016

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

J Clin Oncol 2015 Dec 2;33(35):4167-75. Epub 2015 Nov 2.

Steven M. Devine and William Blum, Ohio State University, Columbus, OH; Kouros Owzar, Flora Mulkey, Vera Hars, and Alexander B. Sibley, Alliance Statistics and Data Center, Duke University, Durham; Thomas C. Shea, University of North Carolina, Chapel Hill, NC; Richard M. Stone, Robert J. Soiffer, and Edwin P. Alyea, Dana-Farber Cancer Institute; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Jack W. Hsu, University of Florida, Gainesville, FL; Richard E. Champlin, MD Anderson Cancer Research Center, Houston, TX; Ravi Vij, Washington University, St. Louis, MO; James Slack, Mayo Clinic, Scottsdale, AZ; Richard A. Larson, University of Chicago, Chicago, IL; Sergio Giralt, Memorial Sloan Kettering Cancer Center, New York, NY; Shelly Carter, The EMMES Corporation, Bethesda, MD; Mary M. Horowitz, Medical College of Wisconsin, Milwaukee, WI; and Charles Linker, University of California at San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.7273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658453PMC
December 2015

Improved accuracy of acute graft-versus-host disease staging among multiple centers.

Best Pract Res Clin Haematol 2014 Sep-Dec;27(3-4):283-7. Epub 2014 Oct 15.

Translational Research Center, The Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai Hospital, 1470 Madison Avenue, New York, NY 10029, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381784PMC
July 2015

Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.

J Am Acad Dermatol 2014 Oct 1;71(4):745-53. Epub 2014 Jul 1.

Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.05.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165782PMC
October 2014

Genetic modification of T cells redirected toward CS1 enhances eradication of myeloma cells.

Clin Cancer Res 2014 Aug 27;20(15):3989-4000. Epub 2014 Mar 27.

Division of Hematology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2510DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119545PMC
August 2014

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.

J Clin Oncol 2014 Aug 30;32(22):2365-72. Epub 2014 Jun 30.

Edmund K. Waller and Wayne A.C. Harris, Emory University, Atlanta, GA; Brent R. Logan, Medical College of Wisconsin, Milwaukee, WI; Steven M. Devine, Ohio State University, Columbus, OH; David L. Porter, University of Pennsylvania, Philadelphia, PA; Shin Mineishi, University of Alabama at Birmingham, Birmingham, AL; John M. McCarty, Medical College of Virginia, Richmond, VA; Corina E. Gonzalez, Georgetown University Hospital, Washington, DC; Thomas R. Spitzer, Massachusetts General Hospital, Boston, MA; Oleg I. Krijanovski, Sutter East Bay Medical Foundation, Berkeley, CA; Michael L. Linenberger and Ann Woolfrey, Fred Hutchinson Cancer Research Center, Seattle, WA; Alan Howard and Dennis L. Confer, National Marrow Donor Program, Minneapolis, MN; Juan Wu, EMMES Corporation, Rockville, MD; and Claudio Anasetti, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.4577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180368PMC
August 2014

FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome.

Biol Blood Marrow Transplant 2014 Mar 21;20(3):309-13. Epub 2013 Dec 21.

Division of Hematology, Department of Internal Medicine, College of Medicine, Ohio State University, Columbus, Ohio; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio; Blood and Marrow Transplantation Program, The James Cancer Hospital, Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.11.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943635PMC
March 2014

Graft-versus-host disease: why have we not made more progress?

Curr Opin Hematol 2014 Mar;21(2):141-7

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131840PMC
March 2014

Reprint of: Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis.

Authors:
Steven M Devine

Biol Blood Marrow Transplant 2014 Feb 12;20(2 Suppl):S2-S7. Epub 2014 Jan 12.

Blood and Marrow Transplant Program, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791140001
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2013.11.035DOI Listing
February 2014

Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis.

Authors:
Steven M Devine

Biol Blood Marrow Transplant 2014 Jan 27;20(1):14-9. Epub 2013 Nov 27.

Blood and Marrow Transplant Program, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791130055
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2013.11.015DOI Listing
January 2014

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.

J Clin Oncol 2013 Nov 14;31(33):4199-206. Epub 2013 Oct 14.

Philippe Armand and Edie Weller, Dana-Farber Cancer Institute; David E. Avigan, Beth Israel Deaconess Medical Center; Yi-Bin Chen, Massachusetts General Hospital, Boston, MA; Arnon Nagler, Chaim Sheba Medical Center, Tel-Hashomer; Reuven Or, Hadassah Medical Center, Jerusalem; Rinat Rotem-Yehudar, CureTech, Yavne, Israel; Steven M. Devine, The Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus; Hillard M. Lazarus, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH; Mark S. Kaminski, University of Michigan, Ann Arbor, MI; H. Kent Holland, Northside Hospital; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine; Stephanie A. Gregory, Rush Medical Center, Chicago, IL; James R. Mason, Scripps Clinic; Edward D. Ball, Moores University of California at San Diego Cancer Center, University of California, San Diego; John M. Timmerman and David Andorsky, University of California, Los Angeles, Los Angeles, CA; Joseph W. Fay, Baylor Research Institute, Baylor University Medical Center, Dallas; Chitra M. Hosing, The University of Texas MD Anderson Cancer Center, Houston, TX; David A. Rizzieri, Duke Cancer Center, Durham, NC; Joseph P. Uberti, Karmanos Cancer Institute, Detroit, MI; Markus Y. Mapara, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2012.48.3685
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.48.3685DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878008PMC
November 2013

Toward a more rational policy for autologous hematopoietic stem cell mobilization.

Authors:
Steven M Devine

Biol Blood Marrow Transplant 2012 Oct 11;18(10):1468-70. Epub 2012 Aug 11.

Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791120031
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2012.08.001DOI Listing
October 2012

Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myeloma.

Clin Lymphoma Myeloma Leuk 2012 Oct 15;12(5):325-9. Epub 2012 Sep 15.

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, the Ohio State University Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2012.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481157PMC
October 2012

Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2012 Aug 30;18(8):1250-4. Epub 2012 Jan 30.

Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University Medical Center, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.01.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378799PMC
August 2012

Can we build a better allograft?

Authors:
Steven M Devine

Blood 2011 Dec;118(25):6478-9

The Ohio State University Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-10-38
Publisher Site
http://dx.doi.org/10.1182/blood-2011-10-386524DOI Listing
December 2011

Hematopoietic stem cell transplantation for cutaneous T-cell lymphoma.

Authors:
Steven M Devine

Clin Lymphoma Myeloma Leuk 2010 Sep;10 Suppl 2:S96-8

The Ohio State University Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2010.s.018DOI Listing
September 2010

Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias.

Haematologica 2010 Jul 11;95(7):1098-105. Epub 2010 May 11.

Division of Hematology and Oncology and the Comprehensive Cancer Center, Department of Medicine, The Ohio State University, B310 Starling-Loving Hall, 320 West 10 Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.017103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895033PMC
July 2010

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas.

Biol Blood Marrow Transplant 2009 May 9;15(5):547-53. Epub 2009 Mar 9.

Hematology and Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.01.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953134PMC
May 2009

Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.

Leuk Lymphoma 2009 Mar;50(3):349-56

Division of Hematology-Oncology, Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190902730227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695225PMC
March 2009

High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Eur J Haematol 2008 Dec 4;81(6):425-31. Epub 2008 Sep 4.

Department of Internal Medicine, Division of Hematology-Oncology, Arthur G James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2008.01146.xDOI Listing
December 2008

Feasibility of allogeneic hematopoietic stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Leuk Lymphoma 2008 Oct;49(10):1893-8

Department of Hematology and Oncology and Bone Marrow Transplantation, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/1042819080227090
Publisher Site
http://dx.doi.org/10.1080/10428190802270902DOI Listing
October 2008

Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.

Biol Blood Marrow Transplant 2008 Jul;14(7):840-6

Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.05.002DOI Listing
July 2008

A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.

Biol Blood Marrow Transplant 2007 Oct;13(10):1201-6

Division of Oncology, Section of Leukemia & Bone Marrow Transplantation, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387910700337
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2007.06.012DOI Listing
October 2007

Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.

Biol Blood Marrow Transplant 2007 Apr;13(4):398-411

Department of Internal Medicine, Division of Oncology, Hematopoietic Development and Malignancy Group, Washington University School of Medicine, 4940 Parkview Place, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2006.12.445DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868544PMC
April 2007

Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system.

Infect Control Hosp Epidemiol 2007 Feb 26;28(2):208-11. Epub 2007 Jan 26.

Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S019594170
Publisher Site
http://dx.doi.org/10.1086/511792DOI Listing
February 2007

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

Blood 2006 Dec 15;108(12):3662-7. Epub 2006 Aug 15.

Division of Oncology, Department of Medicine, 660 S Euclid Ave, Campus Box 8007, Saint Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-06-030577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895468PMC
December 2006

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.

Blood 2005 Sep 12;106(5):1867-74. Epub 2005 May 12.

Thomas Jefferson University, 125 S Ninth St, Ste 801 Sheridan Bldg, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2005-02-04
Publisher Site
http://dx.doi.org/10.1182/blood-2005-02-0468DOI Listing
September 2005